152 related articles for article (PubMed ID: 2787713)
1. Nodular sclerosing, mixed cellularity and lymphocyte-depleted variants of Hodgkin's disease are probable dendritic cell malignancies.
Kennedy IC; Hart DN; Colls BM; Nimmo JC; Willis DA; Angus HB
Clin Exp Immunol; 1989 Jun; 76(3):324-31. PubMed ID: 2787713
[TBL] [Abstract][Full Text] [Related]
2. Immunopathology of Hodgkin's disease. Characterization of Reed-Sternberg cells with monoclonal antibodies.
Strauchen JA; Dimitriu-Bona A
Am J Pathol; 1986 May; 123(2):293-300. PubMed ID: 3085509
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin's disease, lymphocyte predominance type, nodular--a distinct entity? Unique staining profile for L&H variants of Reed-Sternberg cells defined by monoclonal antibodies to leukocyte common antigen, granulocyte-specific antigen, and B-cell-specific antigen.
Pinkus GS; Said JW
Am J Pathol; 1985 Jan; 118(1):1-6. PubMed ID: 3155594
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
Pinkus GS; Said JW
Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
[TBL] [Abstract][Full Text] [Related]
5. Production and characterization of a monoclonal antibody that binds Reed-Sternberg cells.
Hecht TT; Longo DL; Cossman J; Bolen JB; Hsu SM; Israel M; Fisher RI
J Immunol; 1985 Jun; 134(6):4231-6. PubMed ID: 3157756
[TBL] [Abstract][Full Text] [Related]
6. Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease.
Kadin ME; Muramoto L; Said J
Am J Pathol; 1988 Feb; 130(2):345-53. PubMed ID: 2963547
[TBL] [Abstract][Full Text] [Related]
7. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
[TBL] [Abstract][Full Text] [Related]
8. Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen.
Delsol G; Meggetto F; Brousset P; Cohen-Knafo E; al Saati T; Rochaix P; Gorguet B; Rubin B; Voigt JJ; Chittal S
Am J Pathol; 1993 Jun; 142(6):1729-38. PubMed ID: 7685151
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease.
Borowitz MJ; Croker BP; Metzgar RS
Cancer Treat Rep; 1982 Apr; 66(4):667-74. PubMed ID: 6210433
[TBL] [Abstract][Full Text] [Related]
10. Anti-Leu-3a antibody reactivity with Reed-Sternberg cells of Hodgkin's disease.
Oka K; Mori N; Kojima M
Arch Pathol Lab Med; 1988 Feb; 112(2):139-42. PubMed ID: 3257383
[TBL] [Abstract][Full Text] [Related]
11. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
Pinkus GS; Thomas P; Said JW
Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
[TBL] [Abstract][Full Text] [Related]
12. Neoplastic cells obtained from Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures.
Fisher RI; Bostick-Bruton F; Sauder DN; Scala G; Diehl V
J Immunol; 1983 Jun; 130(6):2666-70. PubMed ID: 6222113
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic expression of Hodgkin's and Reed-Sternberg cells in Hodgkin's disease.
Hsu SM; Yang K; Jaffe ES
Am J Pathol; 1985 Feb; 118(2):209-17. PubMed ID: 3970138
[TBL] [Abstract][Full Text] [Related]
14. Hodgkin's disease cell lines: a model for interleukin-1-independent accessory cell function.
McKenzie JL; Egner W; Calder VL; Hart DN
Immunology; 1992 Nov; 77(3):345-53. PubMed ID: 1478681
[TBL] [Abstract][Full Text] [Related]
15. Neoplastic cells obtained from Hodgkin's disease function as accessory cells for mitogen-induced human T cell proliferative responses.
Fisher RI; Bates SE; Bostick-Bruton F; Tuteja N; Diehl V
J Immunol; 1984 May; 132(5):2672-7. PubMed ID: 6609204
[TBL] [Abstract][Full Text] [Related]
16. Antigen presentation by Hodgkin's disease cells.
Fisher RI; Cossman J; Diehl V; Volkman DJ
J Immunol; 1985 Nov; 135(5):3568-71. PubMed ID: 3876389
[TBL] [Abstract][Full Text] [Related]
17. Histogenesis of Reed-Sternberg and dendritic interdigitating cells in nodular sclerosing Hodgkin's disease. Immunohistochemical evidence for monocytoid precursors.
Brown RE
Ann Clin Lab Sci; 1997; 27(5):329-37. PubMed ID: 9303171
[TBL] [Abstract][Full Text] [Related]
18. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
Timens W; Visser L; Poppema S
Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's disease, mixed cellularity type, with a B-cell immunophenotype. Report of a case and literature review.
Siebert JD; McClure SP; Banks PM; Gulley ML
Arch Pathol Lab Med; 1995 May; 119(5):474-9. PubMed ID: 7538289
[TBL] [Abstract][Full Text] [Related]
20. Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma). A variant of the B-cell-derived nodular type.
Hansmann ML; Stein H; Dallenbach F; Fellbaum C
Am J Pathol; 1991 Jan; 138(1):29-36. PubMed ID: 1987769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
